Macular Edema
Showing NaN - NaN of 9
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Macular Edema
- Retinal Vein Occlusion
- KSI-301
- +2 more
-
Phoenix, Arizona
- +140 more
Jul 20, 2022
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, Lucentis or Avastin)
Terminated
- Macular Edema
- Retinal Vein Occlusion
- suprachoroidal CLS-TA
- +2 more
-
Phoenix, Arizona
- +91 more
Apr 22, 2021
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, IVT aflibercept)
Terminated
- Macular Edema
- Retinal Vein Occlusion
- suprachoroidal CLS-TA
- +2 more
-
Peoria, Arizona
- +109 more
Mar 18, 2021
Macular Edema, Retinal Vein Occlusion Trial in United States (4 mg CLS-TA, Sham, IVT aflibercept)
Completed
- Macular Edema
- Retinal Vein Occlusion
- 4 mg CLS-TA
- +2 more
-
Phoenix, Arizona
- +13 more
Jan 18, 2021
Efficacy of RVO in Subjects Who Completed Parent Study
Completed
- Macular Edema
- Retinal Vein Occlusion
-
San Antonio, Texas(unnamed)
Dec 19, 2019
OZURDEX® in Diabetic Macular Edema (DME)
Completed
- Macular Edema
- dexamethasone 700 ㎍ intravitreal implant
-
Phoenix, Arizona
- +17 more
May 31, 2016
Patients Receiving Two or More OZURDEX® Injections for Retinal
Completed
- Retinal Vein Occlusion
- Macular Edema
- dexamethasone intravitreal implant 0.7 mg
-
San Antonio, Texas(unnamed)
Mar 4, 2013